Join Us

 Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron Pharmaceuticals’ offer for the DNA-testing company in a bankruptcy auction. Last month, Regeneron agreed to buy the firm for $256 million, topping a $146…

Finance Newsletter

Subscribe for News and Alerts

Get the latest USA news, updates, and many more news and tips directly to your inbox, join our newsletter now to stay updated.

Money & Finance

View More

The New York Post may receive revenue from affiliate/advertising partnerships for sharing this content and/or if you click or make a purchase. Cryptocurrency investors eager to discover the next breakout project will find it essential to understand how to navigate…

Politics

View More

Lifestyle

View More

Entertainment

View More

Latest News

View More

Most Popular